SCHEMBL24933210

SCHEMBL24933210

CNC(=O)c1ccc(COc2ccc(-c3cc(C(N)=O)c(=O)[nH]c3C(F)(F)F)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.47
MRGPRX4 Q96LA9 1/20 0.42
PARP10 Q53GL7 3/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
HDAC3 O15379 1/20 0.40
PARP1 P09874 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
MMP3 P08254 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30240659 0.90 MRGPRX4 (0.49) MAOBMRGPRX4PARP10ALDH1A1MAPT
SCHEMBL24933648 0.90 MRGPRX4 (0.49) MAOBMRGPRX4PARP10ALDH1A1MAPT
SCHEMBL24933671 0.88 MAOB (0.56) MAOBMRGPRX4SMPD1
SCHEMBL24933182 0.88 HSD17B1 (0.44) HDAC4HDAC6PLK1
SCHEMBL24933637 0.88 MAOB (0.44) MAOBPARP10ALDH1A1MAPTHTT
SCHEMBL24933474 0.87 MAOB (0.45) MAOBPARP10ALDH1A1MAPTHDAC3
SCHEMBL24933349 0.85 GSTP1 (0.50) MAOBPARP10MCL1
SCHEMBL24933352 0.85 MAOB (0.42) MAOBPARP10HDAC3PARP1HDAC4
SCHEMBL24933351 0.84 MAOB (0.41) MAOBPARP10HDAC3PARP1HDAC4
SCHEMBL24933800 0.84 KCNH2 (0.44) MAOBPARP10HDAC3PARP1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed